BMC Infectious Diseases is calling for submissions to our Collection on The rise of invasive fungal infections: diagnostics, antifungal stewardship, prophylaxis, and genetics.

In recent years, the incidence of invasive fungal infections (IFI) has shown a concerning upward trend, presenting a formidable challenge in clinical settings worldwide. This Collection aims to explore multidimensional aspects crucial for understanding and combating these infections. We invite submissions that explore a wide array of topics within the scope of IFI, including but not limited to:

- Diagnostics: advances in fungal diagnostics, including novel biomarkers, imaging modalities, and molecular techniques, are pivotal for timely and accurate identification of fungal pathogens

- Antifungal stewardship: the prudent use of antifungal agents to mitigate resistance and optimize patient outcomes, and strategies for stewardship (including surveillance, guidelines, and therapeutic drug monitoring)

- Antifungal prophylaxis: effective prophylactic measures in high-risk patient populations (examining prophylactic regimens, their efficacy, and impact on patient outcomes)

- Host and pathogen genetics: understanding the genetic factors influencing both host susceptibility and fungal virulence, and research on genetic markers, host-pathogen interactions, and implications for personalized treatment approaches

- Fungal genetics: insights into fungal genome characteristics, evolution, and mechanisms of resistance, and research exploring fungal genetic diversity, adaptation, and transmission dynamics

- Imaging: imaging technologies that contribute significantly to the diagnosis and management of invasive fungal infections, their clinical utility, and integration with diagnostic algorithms

This Collection aims to foster a dialogue among researchers, clinicians, and healthcare providers on the complexities surrounding IFI. This Collection supports and amplifies research related to SDG 3: Good Health & Well-being.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

BMC Infectious Diseases invites submissions for a Collection on Cutting-edge diagnostics for infectious diseases.

The field of diagnostics for infectious diseases is rapidly evolving, driven by the need for timely and accurate detection methods. Traditional diagnostic techniques often fall short in terms of speed and sensitivity, highlighting a pressing need for innovative solutions. Recent advances in technologies such as molecular diagnostics, biosensors, and next-generation sequencing are paving the way for more efficient and reliable testing methodologies. These emerging approaches have the potential to revolutionize the identification of pathogens, enabling faster clinical decision-making and improving patient outcomes.

Addressing the challenges posed by infectious diseases is critical, particularly in an era marked by global health crises and the rise of antimicrobial resistance. The development and implementation of rapid diagnostic tools can facilitate timely interventions, ultimately reducing morbidity and mortality rates. As researchers and healthcare professionals work collaboratively, significant strides have been made in understanding the complexities of infectious diseases. This includes the adaptation of point-of-care testing technologies that bring laboratory capabilities closer to patients, thus enhancing the capacity for early diagnosis and treatment.

If current research trends continue, we may see transformative advancements that integrate artificial intelligence and machine learning into diagnostic processes. Such innovations could lead to the creation of smart diagnostics that not only detect infections with high accuracy but also provide real-time surveillance data. Future technologies may enable rapid identification of emerging pathogens, thus enhancing public health response strategies and mitigating outbreaks before they escalate.

- Advances in molecular diagnostics for infectious diseases

- Innovations in rapid diagnostic testing

- Applications of next-generation sequencing in pathogen detection

- Biosensors for real-time infectious disease monitoring

- Point-of-care testing technologies and their impact

This Collection supports and amplifies research related to SDG 3: Good Health and Well-being.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.